Comparison of 5‐year outcomes of paclitaxel‐eluting and endeavor zotarolimus‐eluting stents in New York
Sign Up to like & getrecommendations! Published in 2018 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.27000
Abstract: To evaluate long‐term outcomes in patients undergoing either paclitaxel‐eluting stents (PES) or endeavor zotarolimus‐eluting stents (E‐ZES) placement and to assess comparative effectiveness of PES vs. E‐ZES in different “off‐label” and “high‐risk” patient subgroups. read more here.
Keywords: endeavor zotarolimus; zotarolimus eluting; paclitaxel eluting; eluting stents ... See more keywords
Long-term comparative effectiveness of Endeavor zotarolimus-eluting and everolimus-eluting stents in New York.
Sign Up to like & getrecommendations! Published in 2017 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2017.03.095
Abstract: BACKGROUND Endeavor zotarolimus-eluting stents (E-ZES) and everolimus-eluting stents (EES) as second-generation stents were approved for use in percutaneous coronary interventions (PCIs) in 2008. We aimed to evaluate the long-term outcomes of E-ZES vs. EES using… read more here.
Keywords: zotarolimus eluting; term; eluting stents; long term ... See more keywords